Rb-82

Isotope Rubidium - 82

	Start date	Site	Title	Topic
ML23284A132	27 November 2023		OMB-3150-0010 - Final Supporting Statement for 10 CFR Part 35 Medical Use of Byproduct Material 2023	Brachytherapy
ML23320A242	16 November 2023		Ots Chapter 246-231 Wac Package Transportation (002)	Condition Adverse to Quality Exclusive Use Depleted uranium
ML23257A264	29 September 2023		Summary of August 29, 2023, Public Meeting on Regulatory Basis for Part 35 Rulemaking on Rb-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material
ML23257A263	29 August 2023		Transcript for the August 29, 2023, Public Meeting on Regulatory Basis for Part 35 Rulemaking on Rb-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material	Enforcement Discretion Brachytherapy
ML23240A718	29 August 2023		Slides - Public Meeting on Regulatory Basis for Rb-82 Generators, Emerging Medical Technologies, and Other Medical Use of Byproduct Material	Enforcement Discretion Brachytherapy
ML23241A914	23 August 2023		t180-13 Effective 2021-04-05 Highlighted	Incorporated by reference Condition Adverse to Quality Exclusive Use
ML23241A917	23 August 2023		t180-13 Effective 2022-11-02 Highlighted	Incorporated by reference Condition Adverse to Quality Exclusive Use
ML23270B389	11 August 2023		NRC-2021-000227 - Released Set Part 1	Enforcement Discretion Cyber Security Open House License Renewal Pandemic COVID-19 Brachytherapy Environmental Justice
ML23198A203	20 July 2023		Public Meeting on Information Request-Draft Regulatory Guide 8061, July 20, 2023
ML23187A446	11 July 2023		STC-23-049 Notification of Issuance for Public Comment of the Regulatory Basis for the Rulemaking to Establish Requirements for Rubidium-82 Generators
ML23122A356	30 June 2023		Regulatory Basis: Rulemaking on Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material	Enforcement Discretion Decommissioning Funding Plan Exemption Request Brachytherapy TheraSphere
ML23167A360	14 June 2023		Wac Chapter 246-231 Packaging and Transportation of Radioactive Material	Condition Adverse to Quality
ML23137A012	5 June 2023		OMB-3150-0010 - Draft Supporting Statement for 10 CFR Part 35 Medical Use of Byproduct Material (2023)	Brachytherapy
ML23122A118	3 May 2023		Responses to ACMUI Comments on the Regulatory Basis for the Rulemaking to Establish Requirements for Rb-82 Generators and Emerging Medical Technologies	Brachytherapy
ML21230A318	30 April 2023		DG 8061 (RG 8.39 Rev 2) Release of Patients Administered Radioactive Material	Brachytherapy Eye plaque
ENS 56378	22 February 2023 00:00:00	Utah Valley Regional Medical Center	Leaking Equipment
ENS 56330	31 January 2023 21:45:00	Intermountain Medical Center	Liquid Radioactive Contamination
ML23005A166	5 December 2022		December 5, 2022, Summary of Meeting Advisory Committee on the Medical Uses of Isotopes (ACMUI) Fall 2022
ML23012A007	5 December 2022		Transcript of Meeting of the Advisory Committee on Medical Uses of Isotopes (Acmui), December 5, 2022	Enforcement Discretion Decommissioning Funding Plan Exemption Request Pandemic Brachytherapy TheraSphere
ML22334A102	5 December 2022		Advisory Committee on the Medical Uses of Isotopes (ACMUI) Fall 2022 Meeting Handout	High Radiation Area Enforcement Discretion Decommissioning Funding Plan Brachytherapy
ML22334A269	30 November 2022		Advisory Committee on the Medical Uses of Isotope (ACMUI) Fall 2022 Meeting Handout (Revised)	High Radiation Area Enforcement Discretion Decommissioning Funding Plan Brachytherapy
ML22326A362	22 November 2022		Draft Regulatory Basis Document for the Rulemaking to Establish Requirements for Rubidium-82 Generators and Emerging Medical Technologies for ACMUI Review	Enforcement Discretion Decommissioning Funding Plan Exemption Request Brachytherapy TheraSphere
ML22304A049	31 October 2022		Advisory Committee on the Medical Uses of Isotopes (ACMUI) Agenda December 5-6, 2022
ML22223A178	11 August 2022		VA Amended Regulations 12VAC5-481	Cyber Security Brachytherapy
ML22234A128	7 July 2022	07001486	Spectrum Health Hospitals - NRC Form 591M Part 1 & NRC Form 592M, Inspection Report 07001486/2022001	Brachytherapy Eye plaque
ML22136A225	11 May 2022		MD Regulations 26.12.01.01	Safe Shutdown High Radiation Area Contraband Incorporated by reference Condition Adverse to Quality Decommissioning Funding Plan Authorized possession limits License Renewal Earthquake Deep Dose Equivalent Chernobyl Brachytherapy Static Eliminator Stolen Exclusive Use Overexposure
ML22136A153	10 May 2022		Wisconsin Subchapter VI 157 59 to 72 Draft	Brachytherapy
ML22131A271	9 May 2022		Georgia Regulations Markup 2021	High Radiation Area Incorporated by reference Earthquake Brachytherapy
ML22063A454	26 April 2022		IP 87130 Nuclear Medicine Programs
ML22089A189	5 April 2022		Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring Meeting 2022 Handout	Brachytherapy Stolen
ML22094A102	5 April 2022		Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring Meeting 2022 Revised Handout	Brachytherapy Stolen
ML22066A310	4 March 2022		CRCPD Part T
ENS 55761	1 March 2022 22:15:00	Ihc Health Services Inc. Dba Intermountain Medical Center	Rb-82 Generator Failure
ML22060A212	28 February 2022		Maryland Regulations 26.12.01.01	Safe Shutdown High Radiation Area Contraband Incorporated by reference Condition Adverse to Quality Decommissioning Funding Plan Authorized possession limits License Renewal Earthquake Deep Dose Equivalent Chernobyl Brachytherapy Static Eliminator Stolen Exclusive Use Overexposure
ML22021A339	27 January 2022		M220127: Slides - Strategic Programmatic Overview of the Decommissioning and Low-Level Waste and Nuclear Materials Users Business Lines	Pandemic Coronavirus Brachytherapy
VR-SECY-21-0013, SRM-SECY-21-0013: Rulemaking Plan to Establish Requirements for Rubidium-82 Generators and Emerging Medical Technologies	13 January 2022		SRM-SECY-21-0013: Rulemaking Plan to Establish Requirements for Rubidium-82 Generators and Emerging Medical Technologies
ML21361A198	20 December 2021	Perry	Supplemental Information for Revision 22 to Updated Safety Analysis Report, Chapter 15, Accident Analysis	Safe Shutdown Shutdown Margin Reactor Vessel Water Level Safety Limit Minimum Critical Power Ratio Stroke time Anticipated operational occurrence Safe Shutdown Earthquake Operator Manual Action Abnormal operational transient Scram Discharge Volume Feedwater Controller Failure Earthquake Control of Heavy Loads Fuel cladding Recently irradiated fuel Power change Flow Induced Vibration Coast down
ML21341B436	15 December 2021		Advisory Committee on the Medical Uses of Isotopes (ACMUI) December 15, 2021 Teleconference Meeting Handout	Brachytherapy Stolen Eye plaque
ML22173A148	14 December 2021	07103091	Redacted - IS-DS 2651 - Design, Manufacturing and Operating Specification for the F-522 Family of Transport	Liquid penetrant
ML21326A168	22 November 2021		Draft Revision 2 of Regulatory Guide 8.39, Release of Patients Administered Radioactive Material, for ACMUI Review	Eye plaque
ML21307A186	28 October 2021	Perry	2 to Updated Safety Analysis Report, Chapter 15, Accident Analyses	Safe Shutdown Shutdown Margin Reactor Vessel Water Level Safety Limit Minimum Critical Power Ratio Stroke time Anticipated operational occurrence Safe Shutdown Earthquake Operator Manual Action Abnormal operational transient Scram Discharge Volume Feedwater Controller Failure Earthquake Control of Heavy Loads Fuel cladding Recently irradiated fuel Power change Flow Induced Vibration Coast down
ML21301A027	25 October 2021		Tennessee Regulations 0400-20-07	License Renewal Brachytherapy
ML21301A031	25 October 2021		Tennessee Regulations 0400-20-10	Safe Shutdown Condition Adverse to Quality Decommissioning Funding Plan Authorized possession limits Static Eliminator
ML21286A490	18 October 2021		10-15-2021 Letter to J.Schuerman Re La Proposed Reg to Rats Ids 2018-1 2020-2 and Other Provisions Not Associated with a Rats Id	Brachytherapy
ML22173A184	20 September 2021	07103091	Redacted - Certificate No. CDN/2094/B(U)-96, Revision 4, Package No. F-522 (Docket No. 71-3091)
ML21193A320	7 July 2021		Nd Chapter 33.1-10-13.1	Incorporated by reference Condition Adverse to Quality
ML21104A403	14 April 2021		Summary of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring 2021 Meeting, March 16, 2021	Coronavirus Brachytherapy
ML20303A306	27 October 2020		Ks Cross Reference 2015-3, Revisions to Transportation Safety Requirements and Harmonization with International Atomic Energy Agency Transportation Requirements; Including Corrections	Incorporated by reference
ML20261H508	3 September 2020		Nd Regulations 33.1-10-13.1	Incorporated by reference Condition Adverse to Quality
ML20128J890	30 June 2020		OMB-3150-0010 - Supporting Statement - 10 CFR Part 35 Medical Use of Byproduct Material	Brachytherapy
... further results

Navigation menu

Search